Ignite Creation Date:
2024-05-06 @ 12:22 PM
Last Modification Date:
2024-10-26 @ 12:58 PM
Study NCT ID:
NCT03745287
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-21
First Post:
2018-11-09
Brief Title:
A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Vertex Pharmaceuticals Incorporated
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hemoglobinopathies |
| Sickle Cell Disease |
| Hematological Diseases |
Keywords: